Literature DB >> 18930201

Leiomyomas in both uterine remnants in a woman with the Mayer-Rokitansky-Küster-Hauser syndrome.

Marta Lamarca1, Ricardo Navarro, María Eugenia Ballesteros, Salvador García-Aguirre, María Pilar Conte, José Antonio Duque.   

Abstract

OBJECTIVE: To describe a case of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome associated with bilateral myomas in uterine remnants.
DESIGN: Case report.
SETTING: University hospital. PATIENT(S): A 35-year-old woman with MRKH syndrome and pelvic pain, in whom leiomyomas were diagnosed by imaging techniques. INTERVENTION(S): Diagnostic laparoscopy followed by excision of leiomyomas and uterine remnants by laparotomy. MAIN OUTCOME MEASURE(S): Resolution of symptoms and histologic confirmation of the clinic diagnosis. RESULT(S): After a 6-month follow-up period, the patient was asymptomatic. The histologic examination confirmed MRKH syndrome associated with multiple myomas in both rudimentary uteri. CONCLUSION(S): This is an unusual case of MRKH syndrome associated with bilateral leiomyomas. The excision of the tumors with the adjacent uterine remnants is indicated when they are symptomatic.

Entities:  

Mesh:

Year:  2008        PMID: 18930201     DOI: 10.1016/j.fertnstert.2008.08.132

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Magnetic resonance evaluation of Müllerian remnants in Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Roh-Eul Yoo; Jeong Yeon Cho; Sang Youn Kim; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

Review 2.  The Rare, Unexpected Condition of a Twisted Leiomyoma in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: Etiopathogenesis, Diagnosis and Management. Our Experience and Narrative Review of the Literature.

Authors:  Federico Romano; Stefania Carlucci; Guglielmo Stabile; Giuseppe Mirenda; Mariateresa Mirandola; Francesco Paolo Mangino; Andrea Romano; Giuseppe Ricci
Journal:  Int J Environ Res Public Health       Date:  2021-05-31       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.